Several studies have used MRM to obtain detailed expression profiles of sEV proteins and to identify potential biomarkers such as HSP90 and syndecan-1 in bladder cancer, and annexin A2 and clusterin in Alzheimer's disease [139–141]. Here, ANXA2 is linked to urinary bladder cancer.